HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Israel Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

12/2000Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Israel Research Topics

Disease

2Chronic Hepatitis C
10/2001 - 03/2000
1Infections
08/2015
1Peritonitis
06/2011
1Hepatitis C
10/2001
1Achondroplasia
12/2000
1Type I Thanatophoric Dysplasia
12/2000

Drug/Important Bio-Agent (IBA)

2Interferon-alpha2bIBA
10/2001 - 03/2000
1Anti-Bacterial Agents (Antibiotics)IBA
08/2015
1Proton Pump InhibitorsIBA
06/2011
1Ribavirin (Virazole)FDA LinkGeneric
10/2001
1RNA (Ribonucleic Acid)IBA
10/2001
1Alanine Transaminase (SGPT)IBA
10/2001
1Interferon-alpha (Interferon Alfa)IBA
10/2001
1Codon (Codons)IBA
12/2000
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2000
1InterferonsIBA
03/2000
1IronIBA
03/2000

Therapy/Procedure

3Therapeutics
08/2015 - 03/2000